T. Griffin
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Colorectal Cancer Screening and Detection
- Dermatology top 1%
- Chemotherapy-related skin toxicity
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 13
- Colorectal Cancer Treatments and Studies 4
-
- Cancer therapeutics and mechanisms 3
- Co-authors
- B Osterwalder (5 shared papers)Joanne L. Blum (2 shared papers)Stephen E. Jones (2 shared papers)Patricia LoRusso (1 shared paper)Aman U. Buzdar (1 shared paper)Charles L. Vogel (1 shared paper)Irene Kuter (1 shared paper)Bruno Reigner (4 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Annals of Oncology (2 papers)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
T. Griffin
20 papers receiving 1.7k citations
T. Griffin's Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 1.3k
- Dermatology 259
- Cancer Research 206
- Pulmonary and Respiratory Medicine 243
- Hematology 63
Countries citing papers authored by T. Griffin
This map shows the geographic impact of T. Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Griffin more than expected).
Fields of papers citing papers by T. Griffin
This network shows the impact of papers produced by T. Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Griffin. The network helps show where T. Griffin may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Griffin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer Hit paper breakdown → | 1999 | 657 |
| 2 | 1998 | 224 | |
| 3 | 1998 | 221 | |
| 4 | 2011 | 179 | |
| 5 | 2004 | 131 | |
| 6 | A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors. | 1998 | 75 |
| 7 | 1999 | 69 | |
| 8 | 1983 | 49 | |
| 9 | 2001 | 39 | |
| 10 | 1999 | 38 | |
| 11 | 2007 | 31 | |
| 12 | 2004 | 16 | |
| 13 | Pulmonary reaction associated with neocarzinostatin therapy. | 1978 | 15 |
| 14 | 2006 | 14 | |
| 15 | 2023 | 9 | |
| 16 | Treatment of acute nonlymphocytic leukemia with neocarzinostatin. | 1980 | 6 |
| 17 | 2006 | 5 | |
| 18 | 2004 | 5 | |
| 19 | [A comparative randomized phase-II study of Xeloda (capecitabine) and paclitaxel in patients with breast cancer progressing after anthracycline antibiotics]. | 2000 | 4 |
| 20 | 2004 | 2 |
About T. Griffin
T. Griffin is a scholar working on Oncology, Molecular Biology, Cancer Research, Dermatology and Neurology, having authored 20 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer therapeutics and mechanisms (3 papers), Chemotherapy-related skin toxicity (2 papers), Neuroblastoma Research and Treatments (2 papers), Breast Cancer Treatment Studies (2 papers), Acute Myeloid Leukemia Research (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (1.3k citations), Dermatology (259 citations), Cancer Research (206 citations), Pulmonary and Respiratory Medicine (243 citations) and Hematology (63 citations). T. Griffin has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include B Osterwalder, Joanne L. Blum, Stephen E. Jones, Patricia LoRusso, Aman U. Buzdar, Charles L. Vogel, Irene Kuter, Bruno Reigner, Margaret Astin and Peter W. Rose. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Investigational New Drugs and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.